Navigation Links
Study: Medicare Covers Only Half the Cost of Administering Chemotherapy to Seniors with Cancer
Date:2/4/2010

SCOTTSDALE, Ariz., Feb. 4 /PRNewswire/ -- A comprehensive study of the components of the delivery of modern-day cancer care in community oncology practices revealed that Medicare covers only 56% of the actual costs of administering chemotherapy and providing related infusion room services to seniors with cancer. The remaining costs -- for essential services provided such as treatment planning, care coordination, and follow-up care planning -- are not reimbursed by Medicare, causing many oncology practices to struggle to continue to provide care under the Medicare program.

The study will be presented at the fifth annual Community Oncology Conference, February 5-6, 2010 in Scottsdale, AZ. The conference attracts health care professionals from community settings, where 84% percent of the cancer care in this country is provided, ranging from private practice-based oncologists, hematologists, oncology nurses and pharmacists to practice administrators.

The study by Avalere Health, a strategic healthcare advisory firm, collected detailed qualitative and quantitative data from 76 community oncology practices across the nation, representing 499 oncologists, in order to quantify the full range of services performed by community oncology practices, including those currently reimbursed by Medicare and private insurers as well as many of the services that are unrecognized and thus uncompensated by payers. The study includes data regarding the time physicians and staff spend on each component of care, as well as financial information about the actual capital and expense costs necessary for operating a community oncology practice.

"These results are alarming, especially when one considers that about half of all cancer patients are Medicare patients," said David Eagle, M.D., vice president of COA and partner at Lake Norman Oncology in Mooresville, North Carolina.  Dr. Eagle will be presenting the study results at the annual conference this weekend. He continued, "The study quantifies what we have known – that cuts in Medicare reimbursement have created a crisis in community cancer care that threatens the very existence of the system that treats four in five U.S. cancer patients."

In addition to underpayments for chemotherapy infusion-related services reported in the study, the average oncology practice reported annual bad debt of $500,178.

"Covering co-payments and coinsurance is harder for cancer patients than ever before," said Patrick Cobb, M.D., president of COA and managing partner of Hematology-Oncology Centers of the Northern Rockies in Billings, Montana. "Cancer treatments and medications are more expensive, requiring a larger percentage of patient income to meet their cost sharing responsibilities. As a result, many practices – who turn away patients only as a very last resort – are absorbing these unpaid costs, contributing to their precarious financial situations."

Medicare has already severely cut payments for cancer drug infusion room services — over 25% since 2004. In addition, the Centers for Medicare & Medicaid Services (CMS) will implement even more cuts, reducing payment for drug infusion room services an additional 5% annually, up to 20% by 2013. Other cuts have been made for cancer diagnostic imaging and physician consultation services.  On top of oncology-specific cuts, there will be a 21% payment cut for all physicians' services starting in March 2010 if Congress does not act quickly to stop it.

"The situation is even more troubling when we consider that the Avalere study was conducted last year, before these year-over-year cuts to chemotherapy services payments," continued Dr. Cobb.  "This study calculated that only 56% of infusion-related services are reimbursed by Medicare, which is already unsustainable for most oncology practices.  But we are expecting even more cuts for chemotherapy services -- up to 20% in cuts by the year 2013.  The full effect of these cuts means that Medicare will only reimburse for an even lower 45% of infusion-related cancer care costs."  

Dr. Cobb concluded, "As a long-term solution, community oncologists have proposed specific solutions for addressing the insufficient Medicare payment system, and are working with Members of Congress in support of including these solutions in the current health care reform process."

About Community Oncology Alliance (COA)

COA is a non-profit organization dedicated solely to community oncology.  COA was founded by community oncology to advocate for patients and providers in the community oncology setting, where 84 percent of Americans with cancer are treated. In only six years of existence, COA has mobilized community oncology to become more politically active, and increased awareness on Capitol Hill about the community cancer care delivery system. Additionally, COA has brought together community oncology practices from across the country to share information in order to enhance the effectiveness and efficiency of the cancer care they provide to their patients.

Currently, COA is working with the Congress in providing proactive solutions designed to protect the viability of the nation's cancer care delivery system and patients' access to quality, affordable cancer care.  The cancer death rate in the U.S. has declined due to earlier detection, the quality of treatment, and the accessibility of cancer care. However, according to the American Cancer Society, men still have an approximately one in two lifetime risk of developing cancer, with a risk of one in three for women.   For more information, please visit www.communityoncology.org.

SOURCE Community Oncology Alliance

RELATED LINKS
http://www.communityoncology.org

'/>"/>

SOURCE Community Oncology Alliance
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. New Study: Lp(a) Joins LDL as Heart Disease Risk Factor
2. Study: Era of Rapid Growth in Biomedical Research Over
3. Penn study: Transforming nanowires into nano-tools using cation exchange reactions
4. Kline Study: Better Brushing Habits Boost European Oral Care Sales
5. Medicare Administrator Establishes Reimbursement Coding Policy for Agendias Breast Cancer Recurrence Test MammaPrint(R)
6. Recently Approved Onglyza Is Covered by 44 Percent of Commercial Health Plans But Less Than One Percent of Medicare Plans for The Treatment of Type 2 Diabetes
7. Finance Committee Begins Markup - Lab Fee Converted to Medicare Cut
8. Noridian Medicare Now Covers Renessa(R) Treatment for Incontinence in Women
9. FCSO Selects Burgess as Exclusive Pricing Solution for New Medicare Contract
10. The Medicare Hospital-Acquired Conditions Initiative Will Spur Increased Patient Screening and Potentially Increased Antibiotic Use
11. On-Line Medicare Advisor Saves Seniors Time, Hassle and Money
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/11/2017)... 2017  VMS BioMarketing, a leading provider of patient support ... Nurse Educator (CNE) network, which will launch this week. The ... health care professionals to enhance the patient care experience by ... other health care professionals to help women who have been ... ...
(Date:10/10/2017)... (PRWEB) , ... October 10, 2017 , ... San Diego-based ... of its corporate rebranding initiative announced today. The bold new look is part ... as the company moves into a significant growth period. , It will also expand ...
(Date:10/10/2017)... SomaGenics announced the receipt of a Phase ... (Single Cell), expected to be the first commercially available ... from single cells using NGS methods. The NIH,s recent ... development of approaches to analyze the heterogeneity of cell ... for measuring levels of mRNAs in individual cells have ...
(Date:10/9/2017)... ... , ... At its national board meeting in North Carolina, ARCS® Foundation ... of Physics and Astronomy, has been selected for membership in ARCS Alumni Hall ... 2015 Breakthrough Prize in Fundamental physics for the discovery of the accelerating expansion of ...
Breaking Biology Technology:
(Date:4/11/2017)... 2017 Research and Markets has announced the ... to their offering. ... eye tracking market to grow at a CAGR of 30.37% during ... Market 2017-2021, has been prepared based on an in-depth market analysis ... and its growth prospects over the coming years. The report also ...
(Date:4/5/2017)... -- The Allen Institute for Cell Science today announces the ... and dynamic digital window into the human cell. The ... of deep learning to create predictive models of cell ... growing suite of powerful tools. The Allen Cell Explorer ... available resources created and shared by the Allen Institute ...
(Date:4/3/2017)... , April 3, 2017  Data captured ... engineering platform, detected a statistically significant association ... prior to treatment and objective response of ... potential to predict whether cancer patients will ... treatment, as well as to improve both pre-infusion ...
Breaking Biology News(10 mins):